SEER INC. - CLASS A COMMON STOCK

Seer’s Proteomics Platform Named as Top 10 Innovation in 2022 by The Scientist

12 Dec 2022 10:00:00 By Nasdaq GlobeNewswire

Seer Reports Third Quarter 2022 Financial Results

08 Nov 2022 16:05:01 By Nasdaq GlobeNewswire

Seer to Report Third Quarter 2022 Financial Results on November 8, 2022

13 Oct 2022 16:15:00 By Nasdaq GlobeNewswire

Seer to Participate in the Morgan Stanley Global Healthcare Conference

30 Aug 2022 16:05:01 By Nasdaq GlobeNewswire

Seer Announces Publication of Seminal Study Demonstrating the Power of Engineered Nano-Bio Interactions to Enable Deep Access to the Proteome

23 Aug 2022 08:00:01 By Nasdaq GlobeNewswire

Seer Reports Second Quarter 2022 Financial Results

09 Aug 2022 16:05:01 By Nasdaq GlobeNewswire

Seer Launches First-of-its-kind Proteogenomics Workflow to Link Genetic Changes with Protein Variants with Proteograph™ Analysis Suite 2.0

03 Aug 2022 09:00:00 By Nasdaq GlobeNewswire

Seer to Report Second Quarter 2022 Financial Results on August 9, 2022

14 Jul 2022 16:05:00 By Nasdaq GlobeNewswire

Seer Reports First Quarter 2022 Financial Results

04 May 2022 16:05:02 By Nasdaq GlobeNewswire

Seer to Present at the BofA Securities 2022 Healthcare Conference

28 Apr 2022 16:05:00 By Nasdaq GlobeNewswire

Seer to Report First Quarter Financial Results on May 4, 2022

07 Apr 2022 16:05:00 By Nasdaq GlobeNewswire

Seer Announces Appointment of Scott D. Thomas as Chief Commercial Officer

16 Mar 2022 16:05:00 By Nasdaq GlobeNewswire

Seer Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Full Year 2022 Outlook

28 Feb 2022 16:05:01 By Nasdaq GlobeNewswire

Seer to Present at the Cowen 42nd Annual Health Care Conference

22 Feb 2022 16:05:00 By Nasdaq GlobeNewswire

Seer to Report Fourth Quarter and Full Year 2021 Financial Results on February 28, 2021

01 Feb 2022 16:05:00 By Nasdaq GlobeNewswire

Updated: Seer Announces Broad Commercial Release of the Proteograph™ Product Suite and Launches Centers of Excellence Program

10 Jan 2022 14:58:08 By Nasdaq GlobeNewswire

Seer, Discovery Life Sciences and SCIEX Announce First-Of-Its-Kind Proteogenomics Consortium for Large-Scale Studies

10 Jan 2022 09:00:00 By Nasdaq GlobeNewswire

Seer Announces Broad Commercial Release of the Proteograph™ Product Suite and Launches Centers of Excellence Program

10 Jan 2022 08:00:04 By Nasdaq GlobeNewswire

Seer to Present Virtually at the 40th Annual J.P. Morgan Healthcare Conference

29 Dec 2021 08:05:00 By Nasdaq GlobeNewswire

Seer Appoints Meeta Gulyani to its Board of Directors

29 Nov 2021 16:05:00 By Nasdaq GlobeNewswire